Follow
Mattia Barbareschi
Mattia Barbareschi
S. Chiara Hospital, Trento, Italy
Verified email at apss.tn.it
Title
Cited by
Cited by
Year
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, ...
Journal of clinical oncology 12 (3), 454-466, 1994
6061994
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast
M Barbareschi, L Pecciarini, MG Cangi, E Macrì, A Rizzo, G Viale, ...
The American journal of surgical pathology 25 (8), 1054-1060, 2001
4992001
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
E Leonardi, S Girlando, G Serio, FA Mauri, G Perrone, S Scampini, ...
Journal of clinical pathology 45 (5), 416-419, 1992
3051992
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
M Cigognetti, S Lonardi, S Fisogni, P Balzarini, V Pellegrini, A Tironi, ...
Modern Pathology 28 (8), 1043-1057, 2015
2852015
High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi, P Maisonneuve, D Aldovini, MG Cangi, L Pecciarini, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
2842003
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
G Gasparini, M Barbareschi, C Doglioni, PD Palma, FA Mauri, P Boracchi, ...
Clinical cancer research: an official journal of the American Association …, 1995
2511995
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ...
Clinical Cancer Research 13 (20), 6064-6069, 2007
2462007
Two distinct immunopathological profiles in autopsy lungs of COVID-19
R Nienhold, Y Ciani, VH Koelzer, A Tzankov, JD Haslbauer, T Menter, ...
Nature communications 11 (1), 5086, 2020
2452020
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs
M Barbareschi, B Murer, TV Colby, M Chilosi, E Macri, M Loda, C Doglioni
The American journal of surgical pathology 27 (2), 141-149, 2003
2412003
AKT1E17K in human solid tumours
FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ...
Oncogene 27 (42), 5648-5650, 2008
2362008
Prognostic value of p21 (WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
O Caffo, C Doglioni, S Veronese, M Bonzanini, A Marchetti, F Buttitta, ...
Clinical cancer research: an official journal of the American Association …, 1996
2011996
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
A Marchetti, C Doglioni, M Barbareschi, F Buttitta, S Pellegrini, G Bertacca, ...
Oncogene 12 (6), 1319-1324, 1996
1831996
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size
S Rossi, D Gasparotto, L Toffolatti, C Pastrello, G Gallina, A Marzotto, ...
The American journal of surgical pathology 34 (10), 1480-1491, 2010
1782010
p53 and c-erb B-2 protein expression in breast carcinomas: An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage …
M Barbareschi, E Leonardi, FA Mauri, G Serio, PD Palma
American journal of clinical pathology 98 (4), 408-418, 1992
1781992
Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: a retrospective study of 103 cases with surgical correlation
L Righi, P Graziano, A Fornari, G Rossi, M Barbareschi, A Cavazza, ...
Cancer 117 (15), 3416-3423, 2011
1732011
The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status
C Doglioni, A Dei Tos, L Laurino, C Chiarelli, M Barbareschi, G Viale
Virchows Archiv 424, 47-51, 1994
1661994
ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach
G Pelosi, A Fabbri, F Bianchi, P Maisonneuve, G Rossi, M Barbareschi, ...
Journal of Thoracic Oncology 7 (2), 281-290, 2012
1652012
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up
M Barbareschi, O Caffo, S Veronese, RD Leek, P Fina, S Fox, ...
Human pathology 27 (11), 1149-1155, 1996
1641996
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients
M Rugge, A Meggio, C Pravadelli, M Barbareschi, M Fassan, M Gentilini, ...
Gut 68 (1), 11-17, 2019
1622019
mdm2 gene alterations and mdm2 protein expression in breast carcinomas
A Marchetti, F Buttitta, S Girlando, PD Palma, S Pellegrini, P Fina, ...
The Journal of pathology 175 (1), 31-38, 1995
1561995
The system can't perform the operation now. Try again later.
Articles 1–20